Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis (METHOBIO)
Sponsor: Assistance Publique Hopitaux De Marseille
Terminated
new treatment on the market in direct competition with the new treatment proposed by the study. Recruitment difficulties.
Other terminated trials from Assistance Publique Hopitaux De Marseille
- Bariatric Surgery · Phase NA · May 2024
- Persistent ARDS · Phase PHASE3 · Nov 2023
- Paraganglioma · Phase NA · Oct 2023
- Epilepsy · Phase NA · Jun 2023
- Preterm Infant · Phase NA · May 2023
See all terminations from Assistance Publique Hopitaux De Marseille
A PHASE4 clinical study on Psoriasis, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique Hopitaux De Marseille and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2025 — Dec 2025 [monthly]
Terminated PHASE4
-
Jun 2025 — Sep 2025 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 5 earlier versions
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Sep 2023 [monthly]
Unknown Status PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique Hopitaux De Marseille
For direct contact, visit the study record on ClinicalTrials.gov .